Simeon George, CEO of life sciences investor SR One, speaks to Unquote about raising its first-time fund, the ongoing importance of its relationship with GSK following its spin-out from the company, and the firm's deal pipeline.
Amanda Good joins from Hg as partner; she has prior experience with Bain & Company
New fund is more than double the size of its €550m predecessor, IK Small Cap II Fund, which is now almost fully invested
Company intends to launch a new round of funding later this year, with the goal of raising around $250m
Private debt fund focuses on lower-mid-market companies; its predecessor closed on €706.5m in 2018